Literature DB >> 3753126

Cholestatic hepatic injury related to warfarin exposure.

E Adler, S B Benjamin, H J Zimmerman.   

Abstract

Despite the widespread use of oral anticoagulants derived from 4-hydroxycoumarin, there have been only a small number of well-defined cases of hepatotoxicity. We report a well-defined case of cholestasis following exposure to warfarin sodium (Coumadin). Inadvertent rechallenge reproduced the syndrome. Cholestasis may occur in response to exposure to derivations of 4-hydroxycoumarin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753126

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case.

Authors:  Gian Marco Rosa; Antonello Parodi; Ulrico Dorighi; Federico Carbone; François Mach; Alessandra Quercioli; Fabrizio Montecucco; Nicolas Vuilleumier; Manrico Balbi; Claudio Brunelli
Journal:  World J Clin Cases       Date:  2014-01-16       Impact factor: 1.337

2.  Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

3.  Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals.

Authors:  R Shrivastava; C Delomenie; A Chevalier; G John; B Ekwall; E Walum; R Massingham
Journal:  Cell Biol Toxicol       Date:  1992 Apr-Jun       Impact factor: 6.691

Review 4.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10

5.  Jaundice as a presentation of heart failure.

Authors:  O M P Jolobe
Journal:  J R Soc Med       Date:  2005-12       Impact factor: 18.000

Review 6.  Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS).

Authors:  Katherine J Hahn; Shannon J Morales; James H Lewis
Journal:  Drug Saf Case Rep       Date:  2015-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.